Press Releases about Harrow Inc
From Harrow Health, Inc.
Via Business Wire
Harrow Secures Capital to Close Recently Announced Acquisition
December 16, 2022
From Harrow Health, Inc.
Via Business Wire
Harrow and iOR Partners Expand National Product Supply Agreement
November 30, 2022
From Harrow
Via Business Wire
Harrow Announces Third Quarter 2022 Financial Results
November 14, 2022
From Harrow
Via Business Wire
From Harrow
Via Business Wire
ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation
September 29, 2022
From Harrow
Via Business Wire
Harrow Health Announces Second Quarter 2022 Financial Results
August 09, 2022
From Harrow Health, Inc.
Via Business Wire
From Harrow Health, Inc.
Via Business Wire
From Harrow Health, Inc.
Via Business Wire
From Harrow Health, Inc.
Via Business Wire
Harrow Health to Present at Aegis Virtual Conference
February 15, 2022
From Harrow Health, Inc.
Via Business Wire
Harrow Health Publishes Corporate Transparency Report
February 08, 2022
From Harrow Health, Inc.
Via Business Wire
From Harrow Health, Inc.
Via Business Wire
Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA
January 04, 2022
Via Business Wire
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
December 20, 2021
From Harrow Health, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.